Physician profile
Carlos A Ramirez Neyra
NPI 1023230927
$233,091.76
in general payments reported to CMS, 2019-2025
26 companies · $57K in 2025
The $57K reported for 2025 was more than what 99% of Oral & Maxillofacial Surgery providers received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,923 · 2020: $139 · 2021: $1,015 · 2022: $4,701 · 2023: $80K · 2024: $87K · 2025: $57K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $97K · Consulting Fee: $90K · Travel and Lodging: $21K · Food and Beverage: $9,508 · Debt Forgiveness: $4,448 · Honoraria: $2,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $96,900.00 |
| Consulting Fee | $90,044.72 |
| Travel and Lodging | $20,913.37 |
| Food and Beverage | $9,508.47 |
| Debt Forgiveness | $4,447.74 |
| Honoraria | $2,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $213,602.29 | 2022-2025 | |
| Kls-Martin L.P. | $6,004.06 | 2019-2025 | |
| Straumann USA LLC | $4,447.74 | 2024 | |
| Axogen | $3,980.50 | 2019-2025 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Nerve Connector |
| Stryker Corporation | $1,435.17 | 2023-2025 | Na, Vsp System, Vsp Cranial, Patient-Fitted Tmj Reconstructive Prosthesis System |
| Depuy Synthes Sales INC. | $1,070.66 | 2022-2024 | Trumatch, Matrixmandible, Matrixcombo |
| Biotissue Holdings INC. | $1,014.10 | 2024-2025 | |
| Smith+Nephew, INC. | $236.15 | 2020-2024 | Renasys Touch, Pico 7, Stravix |
| Urgo Medical North America, LLC | $233.80 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Inari Medical, INC. | $169.34 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Access Pro Medical, LLC | $147.01 | 2025 | Matriderm |
| Acera Surgical, INC. | $131.12 | 2023-2025 | Restrata Wound Matrix |
| Zimmer Biomet Holdings, INC. | $130.41 | 2019-2024 | Traumaone |
| Surgenex LLC | $120.30 | 2025 | Pellograft, Ardeograft, Surgraft |
| Atos Medical INC | $79.61 | 2023 | Provox Life Home Hme |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Checkpoint Surgical, INC | $62.97 | 2019-2024 | Checkpoint Stimulators |
| Organogenesis INC. | $45.40 | 2025 | Puraply Wound Matrix |
| Integra Lifesciences Corporation | $31.44 | 2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Solventum Corporation | $27.20 | 2025 | V.A.C. Veraflo Cleanse Choice |
| Kerecis Limited | $22.47 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Mimedx Group, INC. | $20.99 | 2025 | |
| Innovation Technologies INC | $19.38 | 2025 | Irrisept |
| Allergan, INC. | $18.83 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.41 | 2025 | Xifaxan |
| Medtronic, INC. | $14.71 | 2023 | Pteye Parathyroid Detection System |
| Intuitive Surgical, INC. | $7.70 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlos Ramirez Neyra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.